Hellmut Mahler
- Toxicology top 2%
- Forensic Toxicology and Drug Analysis 6
- Biotechnology top 5%
- Pharmacology top 10%
- Cannabis and Cannabinoid Research 7
- Pharmacology top 10%
- Cannabis and Cannabinoid Research 7
-
- Coordination Chemistry and Organometallics 6
- Asymmetric Synthesis and Catalysis 5
- Synthetic Organic Chemistry Methods 2
-
- Psychedelics and Drug Studies 4
-
- Carcinogens and Genotoxicity Assessment 2
-
- Analytical Chemistry and Chromatography 2
- Co-authors
- Manfred BraunStephan KrähenbühlPetra SchulteW. BärJohn M. KramerAurelio PasiSebastian FischerJoerg Hoernschemeyer
- Cited by
- ToxicologyBiotechnologyPharmacology
- Journals
- Forensic Science International (3 papers)Journal of Chromatography B (2 papers)Tetrahedron Letters (1 paper)
- Partner nations
- GermanySwitzerlandNepal
In The Last Decade
Hellmut Mahler
18 papers receiving 653 citations
Peers
Comparison fields: 5 of 82
- Toxicology 105
- Biotechnology 126
- Pharmacology 107
- Pharmacology 43
- Molecular Biology 337
Countries citing papers authored by Hellmut Mahler
This map shows the geographic impact of Hellmut Mahler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hellmut Mahler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hellmut Mahler more than expected).
Fields of papers citing papers by Hellmut Mahler
This network shows the impact of papers produced by Hellmut Mahler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hellmut Mahler. The network helps show where Hellmut Mahler may publish in the future.
Co-authorship network
The 18 scholars most cited alongside Hellmut Mahler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 15 | |
| 2 | 2015 | 29 | |
| 3 | Synthetische Cannabinoide: Verbreitung, Suchtbiologie & aktuelle Perspektive der persönlichen Gesundheitsgefährdung Synthetic Cannabinoids: Spread, Addiction Biology & Current Perspective of Personal Health Hazard | 2015 | 0 |
| 4 | 2015 | 10 | |
| 5 | 2011 | 24 | |
| 6 | 2011 | 15 | |
| 7 | Smoke analysis of adulterated illicit drug preparations | 2011 | 5 |
| 8 | 2008 | 88 | |
| 9 | 2007 | 51 | |
| 10 | 2003 | 28 | |
| 11 | 2001 | 44 | |
| 12 | 1997 | 291 | |
| 13 | 1995 | 9 | |
| 14 | 1991 | 30 | |
| 15 | 1990 | 3 | |
| 16 | 1989 | 8 | |
| 17 | 1989 | 5 | |
| 18 | 1987 | 32 | |
| 19 | 1980 | 8 |
About Hellmut Mahler
Hellmut Mahler is a scholar working on Toxicology, Pharmacology, Pharmaceutical Science, Organic Chemistry and Clinical Psychology, having authored 19 papers that have together received 695 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (7 papers), Forensic Toxicology and Drug Analysis (6 papers), Coordination Chemistry and Organometallics (6 papers), Asymmetric Synthesis and Catalysis (5 papers), Psychedelics and Drug Studies (4 papers), Carcinogens and Genotoxicity Assessment (2 papers), Analytical Chemistry and Chromatography (2 papers) and Synthetic Organic Chemistry Methods (2 papers). The work is most often cited by research in Toxicology (105 citations), Biotechnology (126 citations), Pharmacology (107 citations), Pharmacology (43 citations) and Molecular Biology (337 citations). Hellmut Mahler has collaborated with scholars based in Germany, Switzerland and Nepal. Frequent co-authors include Manfred Braun, Stephan Krähenbühl, Petra Schulte, W. Bär, John M. Kramer, Aurelio Pasi, Sebastian Fischer, Joerg Hoernschemeyer, Wolfgang Weinmann and Thomas Daldrup. Their work appears in journals such as Forensic Science International, Journal of Chromatography B, Tetrahedron Letters, Journal of Mass Spectrometry and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.